Finch
is a Massachusetts-based pharmaceutical company that researches and develops novel microbiome therapies for the treatment of autism spectrum disorders... Read moreFinch
is a Massachusetts-based pharmaceutical company that researches and develops novel microbiome therapies for the treatment of autism spectrum disorders... Read more
News
Feb 06, 2025
Seeking Alpha
Finch: Finch Therapeutics: Post-Trial Decision Can Potentially Drive Shares To Trade Higher
Oct 21, 2024
LD Micro
Press Release: Finch : Finch Announces Delisting from Nasdaq and SEC Deregistration
Aug 13, 2024
Marketscreener
Finch: Finch Therapeutics Group, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
May 10, 2024
Marketscreener
Finch: Finch Therapeutics Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Mar 25, 2024
Owler
Finch Therapeutics Group, Inc.: Finch's revenue changed from $115K in Sep 2023 to $107K in Dec 2023
Mar 25, 2024
Marketscreener
Finch: Finch Therapeutics Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Nov 08, 2023
Marketscreener
Finch: Finch Therapeutics Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Jun 09, 2023
Citybizlist
Finch: Finch Announces Reverse Stock Split of Common Stock
May 10, 2023
Citybizlist
Finch: Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
May 10, 2023
Owler
Finch Therapeutics Group, Inc.: Finch's revenue changed from $861K in Dec 2022 to $614K in Mar 2023
Finch Competitors
1
2
3
4
5
6
7
8
9
10